Early recognition and appropriate pharmacotherapy for mixed depression: the key to resolving complex or treatment-refractory clinical cases
Clinical Neuropsychopharmacology and Therapeutics · 2019
DOI: 10.5234/cnpt.10.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Therapeutics, 2019. Verfasst von Minoru Takeshima. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Takeshima, M. (2019). Early recognition and appropriate pharmacotherapy for mixed depression: the key to resolving complex or treatment-refractory clinical cases. Clinical Neuropsychopharmacology and Therapeutics. https://doi.org/10.5234/cnpt.10.10
Vancouver
Takeshima M. Early recognition and appropriate pharmacotherapy for mixed depression: the key to resolving complex or treatment-refractory clinical cases. Clinical Neuropsychopharmacology and Therapeutics. 2019. doi:10.5234/cnpt.10.10
BibTeX
@article{Takeshima2019,
author = {Takeshima, Minoru},
title = {Early recognition and appropriate pharmacotherapy for mixed depression: the key to resolving complex or treatment-refractory clinical cases},
journal = {Clinical Neuropsychopharmacology and Therapeutics},
year = {2019},
doi = {10.5234/cnpt.10.10}
}
EUVIMED